Literature DB >> 3620130

Estrogen receptors in normal salivary gland and salivary gland carcinoma.

I W Dimery, L A Jones, R P Verjan, A K Raymond, H Goepfert, W K Hong.   

Abstract

To access for possible hormone dependence, 19 samples of normal salivary gland tissue and 14 samples of salivary gland carcinoma were quantitatively analyzed for estrogen receptor (ER) content. A receptor protein content of greater than or equal to 1 fmol/mg of cytosol protein was considered positive. Ten (77%) of 13 histologically normal samples, and four (80%) of five tumor samples obtained from male patients contained ER by this criterion, as did five (83%) of six normal samples and eight (88%) of nine tumor samples obtained from female patients. Mean ER concentrations plus or minus SE in male-derived samples were 2.02 +/- .42 fmol/mg of cytosol protein for normal tissue and 4.35 +/- 1.5 fmol/mg of cytosol protein for tumor tissue; mean ER concentrations in female-derived samples were 3.48 +/- 1.1 fmol/mg of cytosol protein for normal tissue and 12.64 +/- 6.4 fmol/mg of cytosol protein for tumor tissue. Four of eight tumors in women had levels considered to be "hormonally dependent" in breast carcinoma. These findings indicate that salivary gland carcinomas may be hormone-dependent.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3620130     DOI: 10.1001/archotol.1987.01860100060022

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  11 in total

1.  Estrogen and progesterone receptor and p53 gene expression in adenoid cystic cancer.

Authors:  Jose E Barrera; Kenneth R Shroyer; Sherif Said; George Hoernig; Raymond Melrose; Paul D Freedman; Tanya A Wright; Robert O Greer
Journal:  Head Neck Pathol       Date:  2007-10-26

2.  Estrogen receptor expression in salivary gland mucoepidermoid carcinoma and adenoid cystic carcinoma.

Authors:  Fábio Ramôa Pires; Danyel Elias da Cruz Perez; Oslei Paes de Almeida; Luiz Paulo Kowalski
Journal:  Pathol Oncol Res       Date:  2004-09-25       Impact factor: 3.201

3.  Tamoxifen for salivary gland adenoid cystic carcinoma: report of two cases.

Authors:  Adam D Elkin; Charlotte D Jacobs
Journal:  J Cancer Res Clin Oncol       Date:  2008-03-18       Impact factor: 4.553

Review 4.  Current update on established and novel biomarkers in salivary gland carcinoma pathology and the molecular pathways involved.

Authors:  Markus Stenner; J Peter Klussmann
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-12-04       Impact factor: 2.503

Review 5.  The nature of the head and neck cancer.

Authors:  A G Maran; J A Wilson; M N Gaze
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

Review 6.  Chemotherapy for cranial base tumors.

Authors:  H E Jacob
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 7.  Systemic therapy in the management of metastatic or advanced salivary gland cancers.

Authors:  Aymen Lagha; Nesrine Chraiet; Mouna Ayadi; Sarra Krimi; Bassem Allani; Hela Rifi; Henda Raies; Amel Mezlini
Journal:  Head Neck Oncol       Date:  2012-05-04

8.  Novel therapeutic strategies for malignant salivary gland tumors: lessons learned from breast cancer.

Authors:  Ryuichi Murase; Tomoki Sumida; Akiko Ishikawa; Rumi Murase; Sean D McAllister; Hiroyuki Hamakawa; Pierre-Yves Desprez
Journal:  Int J Otolaryngol       Date:  2011-11-21

Review 9.  Management of salivary gland carcinomas - a review.

Authors:  Xiaoli Wang; Yijun Luo; Minghuan Li; Hongjiang Yan; Mingping Sun; Tingyong Fan
Journal:  Oncotarget       Date:  2017-01-17

10.  A hypothesis to relate salivary tumors with mammary and prostate neoplasias.

Authors:  Adriana B Actis
Journal:  Bioinformation       Date:  2005-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.